Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
Eli Lilly (2025) List of covered drugs (drug list or formulary) 2025, United Healthcare Community Plan (2025) Glucagon-like peptide 1 receptor agonists have the potential to revolutionize the attainment of target A1C levels in type 2 diabetesso why is their uptake so low?, Clinical Diabetes (2023) What is a tiered formulary and what does it mean for me?, United Healthcare Frequently asked questions about pharmacy coverage, United Healthcare Clinical and disease management support programs, United Healthcare (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
People who have difficulty with self-injection due to physical limitations
Structured programs can make strength training more accessible and sustainable
.png)
US$ 28.48
US$ 28.78
US$ 24.27
